Skip to content
Catalyst

magnesium(2+)Finding

Magnesium(2+) decreases diastolic blood pressure (setting unspecified)

lowersVery limited evidenceFindingreplicated ×6

01 · The sentence it was drawn from

“Combining all trials, participants receiving magnesium supplements as compared to control did not significantly reduce SBP (mean difference: -1.3 mmHg, 95% CI: -4.0 to 1.5, I(2)=67%), but did statistically significantly reduce DBP (mean difference: -2.2 mmHg, 95% CI: -3.4 to -0.9, I(2)=47%).”
Quoted verbatim from Magnesium supplementation for the management of essential hypertension in adults.
This finding among the 78 findings on its endpoint

magnesium(2+)

Diastolic blood pressure (setting unspecified)

lowers

Effect as reported

−2.2mean difference

CI −3.4 to −0.9

Who
Adults with primary hypertension; pooled randomized trials of oral magnesium supplementation versus placebo, no treatment or usual care
Dose studied
oral magnesium supplementation, doses varied across trials

Very limited evidencePMID 16856052 · 2006

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

03 · The paper

The Cochrane database of systematic reviews
What else it reported1 finding · 1 compound · 1 endpoint

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6Y40B5S4WYVH1SVTWZ1HARV